GrippeEspagneV1, Main, Exploration, bibRecord, 000062

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.

Identifieur interne : 000062 ( Main/Exploration ); précédent : 000061; suivant : 000063

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.

Auteurs : Ainara Mira-Iglesias [Espagne] ; F Xavier L Pez-Labrador [Espagne] ; Beatriz Guglieri-L Pez [Espagne] ; Miguel Tortajada-Girbés [Espagne] ; Víctor Baselga-Moreno [Espagne] ; Laura Cano [Espagne] ; Juan Mollar-Maseres [Espagne] ; Mario Carballido-Fernández [Espagne] ; Germán Schwarz-Chavarri [Espagne] ; Javier Díez-Domingo [Espagne] ; Joan Puig-Barberà [Espagne]

Source :

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [ 1560-7917 ] ; 2018.

RBID : pubmed:29486829

Descripteurs français

KwdFr :
- Adulte d'âge moyen (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (diagnostic), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Hospitalisation (statistiques et données numériques), Humains (MeSH), Laboratoires (MeSH), Mâle (MeSH), RT-PCR (MeSH), Saisons (MeSH), Sous-type H3N2 du virus de la grippe A (isolement et purification), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Surveillance de la population (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Vaccins antigrippaux (pharmacologie), Études prospectives (MeSH).
MESH :
- administration et posologie : Vaccins antigrippaux.
- diagnostic : Grippe humaine.
- immunologie : Vaccins antigrippaux.
- isolement et purification : Sous-type H3N2 du virus de la grippe A.
- pharmacologie : Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Hospitalisation, Vaccination.
- épidémiologie : Espagne, Grippe humaine.
- Adulte d'âge moyen, Femelle, Humains, Laboratoires, Mâle, RT-PCR, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance de la population, Études prospectives.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Aged (MeSH), Aged, 80 and over (MeSH), Female (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Influenza A Virus, H3N2 Subtype (isolation & purification), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza Vaccines (pharmacology), Influenza, Human (diagnosis), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Laboratories (MeSH), Male (MeSH), Middle Aged (MeSH), Population Surveillance (MeSH), Prospective Studies (MeSH), Reverse Transcriptase Polymerase Chain Reaction (MeSH), Seasons (MeSH), Spain (epidemiology), Vaccination (statistics & numerical data).
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , immunology : Influenza Vaccines.
- geographic , epidemiology : Spain.
- diagnosis : Influenza, Human.
- epidemiology : Influenza, Human.
- isolation & purification : Influenza A Virus, H3N2 Subtype.
- chemical , pharmacology : Influenza Vaccines.
- prevention & control : Influenza, Human.
- statistics & numerical data : Hospitalization, Vaccination.
- Aged, Aged, 80 and over, Female, Humans, Laboratories, Male, Middle Aged, Population Surveillance, Prospective Studies, Reverse Transcriptase Polymerase Chain Reaction, Seasons.

Abstract

IntroductionSeasonal influenza vaccination is widely recommended for people with risk factors, especially for people who are elderly. However, influenza vaccine effectiveness (IVE) varies year after year because of the variable antigenic composition of the circulating viruses and the vaccine composition. Methods: We summarise the results of IVE and the impact of previous vaccination among subjects 60 years of age and over in a multicentre prospective study in the Valencia Hospital Surveillance Network for the Study of Influenza and Respiratory Viruses Disease (VAHNSI) in Spain. We applied the test-negative design taking laboratory-confirmed influenza as outcome and vaccination status as exposure. Information about potential confounders was obtained from clinical registries or directly from patients. Results: Adjusted IVE was 19% (95% confidence interval (CI): -15 to 43). For patients vaccinated in the current season but not in the two previous seasons, effectiveness was 49% (95% CI: -20 to 78) and for patients vaccinated in the current and any of two previous seasons, effectiveness was 29% (95% CI: -3 to 52). For those patients not vaccinated in the current season but vaccinated in any of the two previous seasons, effectiveness was 53% (95% CI: 8 to 76). Conclusions: Our data show a low vaccine effectiveness for the 2016/17 influenza season.

DOI: 10.2807/1560-7917.ES.2018.23.8.17-00318
PubMed: 29486829
PubMed Central: PMC5829534

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 00069
to stream Main, to step Curation: 000069

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.</title>
<author><name sortKey="Mira Iglesias, Ainara" sort="Mira Iglesias, Ainara" uniqKey="Mira Iglesias A" first="Ainara" last="Mira-Iglesias">Ainara Mira-Iglesias</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="L Pez Labrador, F Xavier" sort="L Pez Labrador, F Xavier" uniqKey="L Pez Labrador F" first="F Xavier" last="L Pez-Labrador">F Xavier L Pez-Labrador</name>
<affiliation wicri:level="3"><nlm:affiliation>Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guglieri L Pez, Beatriz" sort="Guglieri L Pez, Beatriz" uniqKey="Guglieri L Pez B" first="Beatriz" last="Guglieri-L Pez">Beatriz Guglieri-L Pez</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tortajada Girbes, Miguel" sort="Tortajada Girbes, Miguel" uniqKey="Tortajada Girbes M" first="Miguel" last="Tortajada-Girbés">Miguel Tortajada-Girbés</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Doctor Peset, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Doctor Peset, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baselga Moreno, Victor" sort="Baselga Moreno, Victor" uniqKey="Baselga Moreno V" first="Víctor" last="Baselga-Moreno">Víctor Baselga-Moreno</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cano, Laura" sort="Cano, Laura" uniqKey="Cano L" first="Laura" last="Cano">Laura Cano</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mollar Maseres, Juan" sort="Mollar Maseres, Juan" uniqKey="Mollar Maseres J" first="Juan" last="Mollar-Maseres">Juan Mollar-Maseres</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario y Politécnico La Fe, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Carballido Fernandez, Mario" sort="Carballido Fernandez, Mario" uniqKey="Carballido Fernandez M" first="Mario" last="Carballido-Fernández">Mario Carballido-Fernández</name>
<affiliation wicri:level="1"><nlm:affiliation>Universidad CEU Cardenal Herrera, Castellón, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Universidad CEU Cardenal Herrera, Castellón</wicri:regionArea>
<wicri:noRegion>Castellón</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Hospital General Universitario de Castellón, Castellón, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital General Universitario de Castellón, Castellón</wicri:regionArea>
<wicri:noRegion>Castellón</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwarz Chavarri, German" sort="Schwarz Chavarri, German" uniqKey="Schwarz Chavarri G" first="Germán" last="Schwarz-Chavarri">Germán Schwarz-Chavarri</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital General de Alicante, Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital General de Alicante, Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diez Domingo, Javier" sort="Diez Domingo, Javier" uniqKey="Diez Domingo J" first="Javier" last="Díez-Domingo">Javier Díez-Domingo</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Salud Pública de Castellón, Castellón, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Salud Pública de Castellón, Castellón</wicri:regionArea>
<wicri:noRegion>Castellón</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29486829</idno>
<idno type="pmid">29486829</idno>
<idno type="doi">10.2807/1560-7917.ES.2018.23.8.17-00318</idno>
<idno type="pmc">PMC5829534</idno>
<idno type="wicri:Area/Main/Corpus">00069</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00069</idno>
<idno type="wicri:Area/Main/Curation">000069</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000069</idno>
<idno type="wicri:Area/Main/Exploration">000069</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.</title>
<author><name sortKey="Mira Iglesias, Ainara" sort="Mira Iglesias, Ainara" uniqKey="Mira Iglesias A" first="Ainara" last="Mira-Iglesias">Ainara Mira-Iglesias</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="L Pez Labrador, F Xavier" sort="L Pez Labrador, F Xavier" uniqKey="L Pez Labrador F" first="F Xavier" last="L Pez-Labrador">F Xavier L Pez-Labrador</name>
<affiliation wicri:level="3"><nlm:affiliation>Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guglieri L Pez, Beatriz" sort="Guglieri L Pez, Beatriz" uniqKey="Guglieri L Pez B" first="Beatriz" last="Guglieri-L Pez">Beatriz Guglieri-L Pez</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tortajada Girbes, Miguel" sort="Tortajada Girbes, Miguel" uniqKey="Tortajada Girbes M" first="Miguel" last="Tortajada-Girbés">Miguel Tortajada-Girbés</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Doctor Peset, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Doctor Peset, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baselga Moreno, Victor" sort="Baselga Moreno, Victor" uniqKey="Baselga Moreno V" first="Víctor" last="Baselga-Moreno">Víctor Baselga-Moreno</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cano, Laura" sort="Cano, Laura" uniqKey="Cano L" first="Laura" last="Cano">Laura Cano</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mollar Maseres, Juan" sort="Mollar Maseres, Juan" uniqKey="Mollar Maseres J" first="Juan" last="Mollar-Maseres">Juan Mollar-Maseres</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario y Politécnico La Fe, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Carballido Fernandez, Mario" sort="Carballido Fernandez, Mario" uniqKey="Carballido Fernandez M" first="Mario" last="Carballido-Fernández">Mario Carballido-Fernández</name>
<affiliation wicri:level="1"><nlm:affiliation>Universidad CEU Cardenal Herrera, Castellón, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Universidad CEU Cardenal Herrera, Castellón</wicri:regionArea>
<wicri:noRegion>Castellón</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Hospital General Universitario de Castellón, Castellón, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital General Universitario de Castellón, Castellón</wicri:regionArea>
<wicri:noRegion>Castellón</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwarz Chavarri, German" sort="Schwarz Chavarri, German" uniqKey="Schwarz Chavarri G" first="Germán" last="Schwarz-Chavarri">Germán Schwarz-Chavarri</name>
<affiliation wicri:level="1"><nlm:affiliation>Hospital General de Alicante, Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital General de Alicante, Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diez Domingo, Javier" sort="Diez Domingo, Javier" uniqKey="Diez Domingo J" first="Javier" last="Díez-Domingo">Javier Díez-Domingo</name>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro de Salud Pública de Castellón, Castellón, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Salud Pública de Castellón, Castellón</wicri:regionArea>
<wicri:noRegion>Castellón</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</title>
<idno type="eISSN">1560-7917</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (statistics & numerical data)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H3N2 Subtype (isolation & purification)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza Vaccines (pharmacology)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Laboratories (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Population Surveillance (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Vaccination (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation (statistiques et données numériques)</term>
<term>Humains (MeSH)</term>
<term>Laboratoires (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>RT-PCR (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sous-type H3N2 du virus de la grippe A (isolement et purification)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Vaccination (statistiques et données numériques)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins antigrippaux (pharmacologie)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Laboratories</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Population Surveillance</term>
<term>Prospective Studies</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Seasons</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Laboratoires</term>
<term>Mâle</term>
<term>RT-PCR</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Surveillance de la population</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">IntroductionSeasonal influenza vaccination is widely recommended for people with risk factors, especially for people who are elderly. However, influenza vaccine effectiveness (IVE) varies year after year because of the variable antigenic composition of the circulating viruses and the vaccine composition. <b>Methods:</b>
 We summarise the results of IVE and the impact of previous vaccination among subjects 60 years of age and over in a multicentre prospective study in the Valencia Hospital Surveillance Network for the Study of Influenza and Respiratory Viruses Disease (VAHNSI) in Spain. We applied the test-negative design taking laboratory-confirmed influenza as outcome and vaccination status as exposure. Information about potential confounders was obtained from clinical registries or directly from patients. <b>Results:</b>
 Adjusted IVE was 19% (95% confidence interval (CI): -15 to 43). For patients vaccinated in the current season but not in the two previous seasons, effectiveness was 49% (95% CI: -20 to 78) and for patients vaccinated in the current and any of two previous seasons, effectiveness was 29% (95% CI: -3 to 52). For those patients not vaccinated in the current season but vaccinated in any of the two previous seasons, effectiveness was 53% (95% CI: 8 to 76). <b>Conclusions:</b>
 Our data show a low vaccine effectiveness for the 2016/17 influenza season.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29486829</PMID>
<DateCompleted><Year>2019</Year>
<Month>05</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>05</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>23</Volume>
<Issue>8</Issue>
<PubDate><Year>2018</Year>
<Month>02</Month>
</PubDate>
</JournalIssue>
<Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title>
<ISOAbbreviation>Euro Surveill.</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2018.23.8.17-00318</ELocationID>
<Abstract><AbstractText>IntroductionSeasonal influenza vaccination is widely recommended for people with risk factors, especially for people who are elderly. However, influenza vaccine effectiveness (IVE) varies year after year because of the variable antigenic composition of the circulating viruses and the vaccine composition. <b>Methods:</b>
 We summarise the results of IVE and the impact of previous vaccination among subjects 60 years of age and over in a multicentre prospective study in the Valencia Hospital Surveillance Network for the Study of Influenza and Respiratory Viruses Disease (VAHNSI) in Spain. We applied the test-negative design taking laboratory-confirmed influenza as outcome and vaccination status as exposure. Information about potential confounders was obtained from clinical registries or directly from patients. <b>Results:</b>
 Adjusted IVE was 19% (95% confidence interval (CI): -15 to 43). For patients vaccinated in the current season but not in the two previous seasons, effectiveness was 49% (95% CI: -20 to 78) and for patients vaccinated in the current and any of two previous seasons, effectiveness was 29% (95% CI: -3 to 52). For those patients not vaccinated in the current season but vaccinated in any of the two previous seasons, effectiveness was 53% (95% CI: 8 to 76). <b>Conclusions:</b>
 Our data show a low vaccine effectiveness for the 2016/17 influenza season.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mira-Iglesias</LastName>
<ForeName>Ainara</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>López-Labrador</LastName>
<ForeName>F Xavier</ForeName>
<Initials>FX</Initials>
<AffiliationInfo><Affiliation>Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guglieri-López</LastName>
<ForeName>Beatriz</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tortajada-Girbés</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Hospital Doctor Peset, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baselga-Moreno</LastName>
<ForeName>Víctor</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cano</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mollar-Maseres</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Hospital Universitario y Politécnico La Fe, Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carballido-Fernández</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Universidad CEU Cardenal Herrera, Castellón, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Hospital General Universitario de Castellón, Castellón, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schwarz-Chavarri</LastName>
<ForeName>Germán</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Hospital General de Alicante, Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Díez-Domingo</LastName>
<ForeName>Javier</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Puig-Barberà</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Centro de Salud Pública de Castellón, Castellón, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>Valencia Hospital Network For The Study Of Influenza And Respiratory Viruses Disease</CollectiveName>
<AffiliationInfo><Affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Sweden</Country>
<MedlineTA>Euro Surveill</MedlineTA>
<NlmUniqueID>100887452</NlmUniqueID>
<ISSNLinking>1025-496X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007753" MajorTopicYN="N">Laboratories</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">epidemiology</Keyword>
<Keyword MajorTopicYN="Y">hospitalisations</Keyword>
<Keyword MajorTopicYN="Y">influenza virus</Keyword>
<Keyword MajorTopicYN="Y">surveillance</Keyword>
<Keyword MajorTopicYN="Y">vaccine</Keyword>
<Keyword MajorTopicYN="Y">vaccine effectiveness</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29486829</ArticleId>
<ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.8.17-00318</ArticleId>
<ArticleId IdType="pmc">PMC5829534</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Arch Intern Med. 2005 Feb 14;165(3):265-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15710788</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2015 Feb 26;20(8):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25742432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2017 Feb 23;22(8):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28251889</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2017 Feb 9;22(6):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28205503</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Apr 19;31(17):2165-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23499601</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2017 Feb 16;22(7):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28230524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2017 Aug 3;35(34):4298-4306</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28709555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Aug 20;31(37):3995-4002</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23731629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2008 Sep;152(1-2):25-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18598722</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2018 Feb;23 (5):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29409570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Nov 13;9(11):e112294</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25392931</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):167-171</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28207689</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2017 Feb 16;22(7):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28230523</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2009 Sep;47(9):2772-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19641063</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 Nov 15;59(10):1375-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25270645</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2010 Nov 3;28(47):7460-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20875486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Anti Infect Ther. 2011 Jun;9(6):669-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21692672</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23210147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2013 May;56(10):1363-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23413420</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. 2016 Mar 11;91(10):121-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26971356</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2002 Dec 20;20 Suppl 5:B50-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12477420</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1998 Jul;178(1):53-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9652423</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2016 Jul 1;63(1):21-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27025838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2017 Mar;36(3):e69-e75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27902651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2017 Apr 1;215(7):1059-1099</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28180277</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Epidemiol Community Health. 2006 Feb;60(2):95-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16415256</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Syst Biol. 2010 May;59(3):307-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20525638</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Vaccines. 2014 Dec;13(12):1571-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25348015</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Communauté de Madrid</li>
</region>
<settlement><li>Madrid</li>
</settlement>
</list>
<tree><country name="Espagne"><noRegion><name sortKey="Mira Iglesias, Ainara" sort="Mira Iglesias, Ainara" uniqKey="Mira Iglesias A" first="Ainara" last="Mira-Iglesias">Ainara Mira-Iglesias</name>
</noRegion>
<name sortKey="Baselga Moreno, Victor" sort="Baselga Moreno, Victor" uniqKey="Baselga Moreno V" first="Víctor" last="Baselga-Moreno">Víctor Baselga-Moreno</name>
<name sortKey="Cano, Laura" sort="Cano, Laura" uniqKey="Cano L" first="Laura" last="Cano">Laura Cano</name>
<name sortKey="Carballido Fernandez, Mario" sort="Carballido Fernandez, Mario" uniqKey="Carballido Fernandez M" first="Mario" last="Carballido-Fernández">Mario Carballido-Fernández</name>
<name sortKey="Carballido Fernandez, Mario" sort="Carballido Fernandez, Mario" uniqKey="Carballido Fernandez M" first="Mario" last="Carballido-Fernández">Mario Carballido-Fernández</name>
<name sortKey="Diez Domingo, Javier" sort="Diez Domingo, Javier" uniqKey="Diez Domingo J" first="Javier" last="Díez-Domingo">Javier Díez-Domingo</name>
<name sortKey="Guglieri L Pez, Beatriz" sort="Guglieri L Pez, Beatriz" uniqKey="Guglieri L Pez B" first="Beatriz" last="Guglieri-L Pez">Beatriz Guglieri-L Pez</name>
<name sortKey="L Pez Labrador, F Xavier" sort="L Pez Labrador, F Xavier" uniqKey="L Pez Labrador F" first="F Xavier" last="L Pez-Labrador">F Xavier L Pez-Labrador</name>
<name sortKey="L Pez Labrador, F Xavier" sort="L Pez Labrador, F Xavier" uniqKey="L Pez Labrador F" first="F Xavier" last="L Pez-Labrador">F Xavier L Pez-Labrador</name>
<name sortKey="Mollar Maseres, Juan" sort="Mollar Maseres, Juan" uniqKey="Mollar Maseres J" first="Juan" last="Mollar-Maseres">Juan Mollar-Maseres</name>
<name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<name sortKey="Puig Barbera, Joan" sort="Puig Barbera, Joan" uniqKey="Puig Barbera J" first="Joan" last="Puig-Barberà">Joan Puig-Barberà</name>
<name sortKey="Schwarz Chavarri, German" sort="Schwarz Chavarri, German" uniqKey="Schwarz Chavarri G" first="Germán" last="Schwarz-Chavarri">Germán Schwarz-Chavarri</name>
<name sortKey="Tortajada Girbes, Miguel" sort="Tortajada Girbes, Miguel" uniqKey="Tortajada Girbes M" first="Miguel" last="Tortajada-Girbés">Miguel Tortajada-Girbés</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000062 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000062 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29486829
   |texte=   Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29486829" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021

	Serveur d'exploration sur la grippe en Espagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Espagne

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki